Table 1. Anthropometric Indices, Biochemical Measurements, Blood Pressure and Dietary Intakes of Study Participants at Baseline (Before the Intervention)^a.

Variable	Placebo Group	n-3 PUFA Group	P Valueb
	(N = 21),	(N = 22),
	(M = 13, F = 8)	(M = 12, F = 10)
Age, y	51.34 ± 1.36	48.44 ± 1.42	0.148
Weight, kg	79.3 ± 2.0	79.7 ± 2.22	0.896
Height, m	1.64± 0.18	1.67± 0.01	0.376
BMI, kg/m 2	29.1 ± 0.4	28.39 ± 0.46	0.266
WC, cm	104.3 ± 1.6	99.9 ± 1.4	0.051
HC, cm	106.22 ± 1.23	105.4 ± 1.04	0.609
WHR	0.98 ± 0.01	0.94 ± 0.01	0.064
Duration of illness, y	6.54 ± 0.71	4.54 ± 0.55	0.031
FBS, mg/dL	1.78 ± 9.54	1.75 ± 8.53	0.833
Insulin, µm/mL	12.25 ± 0.91	10.41 ± 0.78	0.153
HbA1C %	7.72 ± 0.22	7.68 ± 0.25	0.902
HOMA.IR %	5.30 ± 0.39	4.57 ± 0.48	0.245
Serum Irisin, µg/mL	1.69 ± 0.20	2.12 ± 0.21	0.152
Systolic BP, mmHg	131.7 ± 2.2	127.2 ± 1.9	0.13
Diastolic BP, mmHg	85.20 ± 1.99	81.66 ± 1.64	0.17
Total energy, kcal	2089 ± 53	2081 ± 43	0.9
Total protein, g	67.74 ± 4.81	72.41 ± 4.78	0.49
Total fat, g	88.59 ±4.65	77.74 ± 3.59	0.06
Total carbohydrate, g	262 ± 7	278 ± 9	0.17
DHA, g	0.05 ± 0.03	0.15 ± 0.09	0.31
EPA, g	0.017 ± 0.01	0.05 ± 0.02	0.31

Abbreviations: BMI, body mass index; BP, blood pressure; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; F, female; HC, hip circumference; M, male; WC, waist circumference; WHR, waist-to-hip ratio.

^aValues are described as mean ± standard error (SE).

^bIndependent sample t-test.